Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01867580 · ClinicalTrials.gov registry record · NA

A Pilot RCT of Veraflo With Prontosan vs VAC in Wounds Requiring Operative Debridement

A NA study of Wounds and Injuries, sponsored by KCI USA.

Completed
Registry status
NA
Development phase
181
Enrollment target
7
Study locations

NCT01867580 is a NA study of Wounds and Injuries that has completed, run by KCI USA. The registered enrollment target is 181 participants, below the 497-participant average among 27 other Wounds and Injuries trials with a reported enrollment target (64% lower). The trial reports 7 study locations across 6 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01867580, a NA study of Wounds and Injuries, has completed, sponsored by KCI USA.

COMPLETED
Registry status
NA
Development phase
181 participants
Enrollment target
7
Study locations

Study Summary

The purpose of this study is to examine the effectiveness of the Veraflo with Prontosan vs VAC in wounds that require operative debridement.

Conditions Studied

Interventions

  • DEVICE V.A.C.Ulta with Prontosan instillation
  • DEVICE V.A.C.Ulta without instillation

Study Locations (7)

Pennsylvania

  • St. Luke's University Hospital - Bethlehem
  • University of Pennsylvania Health System - Philadelphia

District of Columbia

  • Medstar Georgetown University Hospital - Washington D.C.

Florida

  • University of Miami Miller School of Medicine - Miami

Illinois

  • Northwestern University - Chicago

Massachusetts

  • Brigham and Women's Hospital - Boston

Texas

  • University of Texas Southwestern - Dallas

Trial Details

FieldValue
Enrollment Target 181 participants
Start Date 2013-05
Est. Completion 2015-11
Phase NA

Sponsor

KCI USA

11 total trials

What the Registry Record Tells You About NCT01867580

The ClinicalTrials.gov registry entry for NCT01867580 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 181 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 497-participant average among 27 other Wounds and Injuries trials with a reported enrollment target (64% lower). The listed sponsor is KCI USA, which has 11 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Wounds and Injuries appearing as the primary indexed condition, and to 2 interventions - of which V.A.C.Ulta with Prontosan instillation is the first listed.

NCT01867580 reports 7 study locations spanning 6 distinct geographic areas - top geographies include Pennsylvania, District of Columbia, Florida.

Frequently Asked Questions

What is clinical trial NCT01867580 about?

NCT01867580 is a clinical study titled "A Pilot RCT of Veraflo With Prontosan vs VAC in Wounds Requiring Operative Debridement". The purpose of this study is to examine the effectiveness of the Veraflo with Prontosan vs VAC in wounds that require operative debridement.

What is the current status of trial NCT01867580?

This trial is currently completed. It is a NA study. The enrollment target is 181 participants. The study started on 2013-05. Estimated completion is 2015-11.

What conditions does trial NCT01867580 study?

This clinical trial studies the following conditions: Wounds and Injuries.

What interventions are being tested in trial NCT01867580?

The interventions under investigation include: V.A.C.Ulta with Prontosan instillation (DEVICE), V.A.C.Ulta without instillation (DEVICE).

Who is sponsoring clinical trial NCT01867580?

This trial is sponsored by KCI USA, which has 11 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01867580 being conducted?

This trial has 7 study locations across District of Columbia, Florida, Illinois, Massachusetts, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Wounds and Injuries

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.